Abstract
An alkaline kit formulation (pH 9) to obtain [99mTc]MAG3 with radiochemical puritives over 98% has been developed, avoiding the addition of filtered air to the vial, the use of large amounts of99mTc activity (i.e., 3.7 GBq) or the reconstitution of large volumes. The use of this radiopharmaceutical in mice showed a minimal accumulation in the hepatobiliary system (0.37±0.3% I.D., 1 h postinjection). However, in rabbits we always obtained good image quality.
Similar content being viewed by others
References
K. M. Bannister, S. Penglis, J. C. Bellen, R. J. Baker, B. E. Chatterton,J. Nucl. Med., 31 (1990) 1568.
W. Brandau, B. Bubeck, M. Eisenhut, D. M. Taylor,Appl. Radiat Isot. 39 (1988) 121.
A. Davison, A. Jones,Int. J. Appl. Radiat. Isot., 33 (1982) 875.
A. R. Fritzberg, S. Kasina, D. Eshima, L. D. Johnson, J. Nucl. Med., 27 (1986) 111.
C. D. Russell, A. G. Cash,J. Nucl. Med., 20 (1979) 532.
L. A. Shattuck, D. Eshima, A. T. Taylor, T. L. Anderson, D. L. Graham, F. A. Latino, S. E. Payne,J. Nucl. Med., 35 (1994) 349.
A. Yokoyama, N. Hata, K. Horiuchi, H. Masuda, H. Saji, H. Ohta, K. Yamamoto, K. Endo, K. Torizuka,Int. J. Nucl. Med. Biol., 12 (1985) 273.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reyes-Herrera, L., Ferro-Flores, G., Lezama-Carrasco, J. et al. An alkaline kit formulation to obtain [99mTc]MAG3 in high radiochemical yields. Journal of Radioanalytical and Nuclear Chemistry Letters 199, 507–516 (1995). https://doi.org/10.1007/BF02164638
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02164638